HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cradle Holdings CEO

This article was originally published in The Rose Sheet

Executive Summary

Fragrance and skin care company appoints Ralph Mason CEO, effective immediately. Mason comes to the firm from Jafra Cosmetics, where he served as chairman and exec VP since 1998. Exec succeeds Robert Nielsen, who has been elected vice chairman of the board, where he will work on "future acquisitions and overall strategy" while remaining a significant investor in the firm. Nielsen served as the first CEO of Cradle Holdings, which was founded in 2002 to "acquire and nurture promising prestige beauty companies" (1"The Rose Sheet" Feb. 18, 2002, p. 7). Cradle Holdings distributes and markets the Erno Laszlo, Penhaligon's and L'Artisan Parfumeur brands...

You may also be interested in...

Penhaligon’s Owner Cradle Holdings Initiates U.S. Expansion

The specialty UK beauty brand Penhaligon's will undergo its first major U.S. expansion under Cradle Holdings, a new cosmetics business entity formed by private equity firm Fox Paine to "acquire and nurture promising prestige beauty companies.

Nanobiotix CEO’s Expansion Plans Target ‘Millions’ Of Patients

Nanobiotix’s CEO outlines to Scrip how the biotech plans to develop and expand its lead asset into multiple cancer indications, and create a blockbuster.

Teva’s Austedo Fails In Tourette’s Syndrome

Two late-stage trials of Austedo have missed their endpoints in the neurological disorder, meaning Teva will miss out on an additional revenue stream from the VMAT2 inhibitor.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts